Gabelli Funds LLC Vericel Corp Transaction History

Gabelli Funds LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$22.62 - $32.54 $198,988 - $286,254	8,797 New	8,797 $204,000
Q2 2021 Aug 13, 2021	SELL	$47.2 - $67.81 $511,742 - $735,196	-10,842 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$30.93 - $59.48 $185,580 - $356,880	-6,000 Reduced 35.63%	10,842 $602,000
Q2 2020 Aug 13, 2020	BUY	$8.5 - $15.82 $143,157 - $266,440	16,842 New	16,842 $233,000

276

48.5M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.61B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

Stay updated on Gabelli Funds LLC with notifications on news.